Locoregional cutaneous metastasis in patients with therapeutic lymph node dissection for malignant melanoma: Risk factors and prognostic impact

Melanoma Research

Volumn 12, Issue 5, 2002, Pages 499-504

  Kretschmer, L ^a   Preusser K P ^a   Neumann, C ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

In transit melanoma; Lymph node excision; Regional cutaneous metastases; Survival

Indexed keywords

ADULT; ARTICLE; AXILLARY LYMPH NODE; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HUMAN; INGUINAL LYMPH NODE; KAPLAN MEIER METHOD; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MELANOMA; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; RISK FACTOR; SKIN METASTASIS; DISEASE FREE SURVIVAL; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; SKIN TUMOR; TIME;

DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SKIN NEOPLASMS; TIME FACTORS;

EID: 0036752110     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200209000-00012     Document Type: Article

References (15)

1. Wong JH, Cagle LA, Kopald KH, et al. Natural history and selective management of in transit melanoma. J Surg Oncol 1990; 44: 146-150.
2. Santinami M, Belli F, Cascinelli N, et al. Seven years' experience with hyperthermic perfusion in extracorporeal circulation for melanoma of the extremities. J Surg Oncol 1989; 42: 201-208.
3. Singletary S, Tucker S, Boddie A. Multivariate analysis of prognostic factors in regional cutaneous metastases of extremity melanoma. Cancer 1988; 61: 1437-1440.
4. Cascinelli N, Bufalino R, Marolda R, et al. Regional non-nodal metastases of cutaneous melanoma. Eur J Surg Oncol 1986; 12: 175-180.
5. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001; 19: 3635-3648.
6. Coit DG, Rogato A, Brennan MF. Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes. A multivariate analysis. Ann Surg 1991; 214: 627-636.
7. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-486.
8. Cox DR. Regression model and life tables. J Royal Stat Soc 1972; 34: 187-220.
9. Buzaid AC, Ross MI, Balch CM, et al. Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system. J Clin Oncol 1997; 15: 1039-1051.
10. Dong XD, Tyler D, Johnson JL, et al. Analysis of prognosis and disease progression after local recurrence of melanoma. Cancer 2000; 88: 1063-1071.
11. Calabro A, Singletary E, Balch CM. Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases. Arch Surg 1989; 124: 1051-1055.
12. Harrist TJ, Rigel DS, Day CL Jr, et al. 'Microscopic satellites' are more highly associated with regional lymph node metastases than is primary melanoma thickness. Cancer 1984; 53: 2183-2187.
13. Cavaliere R, Cavaliere F, Deraco M, et al. Hyperthermic antiblastic perfusion in the treatment of stage IIIA-IIIAB melanoma patients. Comparison of two experiences. Melanoma Res 1994; 4(suppl 1): 5-11.
14. Krementz ET, Carter RD, Sutherland CM, et al. Regional chemotherapy for melanoma. A 35-year experience. Ann Surg 1994; 220: 520-534.
15. Stehlin JS, Giovanella BC, Gutierrez AF, et al. 15 years' experience with hyperthermic perfusion for treatment of soft tissue sarcoma and malignant melanoma of the extremities. Front Radiat Ther Oncol 1984; 18: 177-182.